Vertex wins approval for new cystic fibrosis therapy Alyftrek Share this:FacebookX Related Post navigation Carl Icahn Buys $860,177 in CVR Partners (NYSE: UAN) Stock By Investing.com Treasuries rise as key Fed inflation numbers come in below estimates